Stock screener

AKTX

Conviction 50HealthcareScan · Tue, Sep 8, 2026
Tweezer top
AKTX$11.20-2.35%
ResistanceSupportVol 14
63 bars
Vol MA14 83.31K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Akari Therapeutics PlcPHARMACEUTICAL PREPARATIONSwww.akaritx.com ↗
Price11.20
Change-2.35%
Gap+1.48%
Rel volume1.25×
Avg volume84.4K
Avg $ vol780.49K
SMA 208.85
SMA 509.61
SMA 2005.12
Price vs 50+16.50%
Price vs 200+118.55%
MA stackbullish
50/200 cross—
Supertrendup · 7.77
RSI (14)64
MACD hist0.42
MACD cross—
Stoch %K / %D86 / 89
ADX (14)29
+DI / −DI26 / 9
RSI divergence—
MACD divergence—
ATR %+10.43%
ADR %10.99%
52w high22.05
52w low0.1210
From 52w high-49.21%
Above 52w low+9156.20%
New 52w highNo
SqueezeOff
Bollinger width67.11%
%B0.90
Donchian pos88.32%
Donchian high11.82
Donchian low6.51
AVWAP (52w high)14.14
vs AVWAP high-20.77%
AVWAP (52w low)13.46
vs AVWAP low-16.81%
OBV trendFlat
Chaikin MF (20)0.22
Today vs 20d1.25×
Avg vol (14d)83.31K
Avg vol (20d)84.4K
Avg $ vol (20d)780.49K
Market cap1.74T
RS 3m (vs SPY)-28.31%
RS 6m (vs SPY)+4451.54%
RS line new highNo
Trend template6/8
Technical rank97.2
1 week+7.38%
1 month+60.00%
3 months-27.48%
6 months+4358.60%
1 year+1268.02%
YTD+3762.07%
P/E—
P/B—
P/S—
P/FCF—
EPS0.0000
Div yield—
ROE-93.03%
ROA-44.79%
Debt/Eq0.01
Current0.60
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth12.60%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value1.74T
Revenue—
Net income-4.81M
Gross profit—
Free cash flow-10.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees5
ListedFri, Dec 7, 2012
Free float1.34M
Float %0.0%
Short interest37.66K
Days to cover0.9d
Short volume71.9%
Squeeze score34 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction50 / 100
Pattern quality—
Tech rank97.2 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmTweezer top
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Breaking out now
    Jun 16
    1 scan
  2. Broke out
    Jul 7
    1 scan

Congress activity

Disclosed STOCK Act trades in AKTX

All disclosures →
No recent disclosed trades by Congress in AKTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AKTX · 10 buys

InsiderSideShares
Farag Kameel D.
Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-08-17
Grant1.73K
Farag Kameel D.
Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-07-16
Grant1.13K
Patel Samir Rashmikant
Director · American Depositary Shares representing Ordinary Shares · 2026-07-07
Exercise1.21K
Patel Samir Rashmikant
Director · American Depositary Shares representing Ordinary Shares · 2026-07-07
Exercise15.47K
Patel Samir Rashmikant
Director · American Depositary Shares representing Ordinary Shares · 2026-07-07
Exercise5.8K
Patel Samir Rashmikant
Director · Pre-Funded Warrant to purchase American Depositary Shares · 2026-07-07
Exercise1.21K
Patel Samir Rashmikant
Director · Pre-Funded Warrant to purchase ADSs · 2026-07-07
Exercise15.47K
Patel Samir Rashmikant
Director · Pre-Funded Warrant to purchase ADSs · 2026-07-07
Exercise5.8K
Gaslightwala Abizer
CEO · Stock Option (Right to Buy) · 2026-06-24
Grant5.5K
Gaslightwala Abizer
CEO · Stock Option (Right to Buy) · 2026-06-24
Grant15.56K

SEC filings

EDGAR filings in AKTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.